+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Ngs-Based Rna-Seq Market 2024-2028

  • PDF Icon

    Report

  • 169 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5697619
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The NGS-based RNA-seq market is forecasted to grow by USD 6.65 billion during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.

The NGS-based RNA-seq market is segmented as below:

By End-user

  • Acamedic and research centers
  • Clinical research
  • Pharma companies
  • Hospitals

By Technology

  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Single-molecule real-time sequencing
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

  • NGS-based RNA-seq market sizing
  • NGS-based RNA-seq market forecast
  • NGS-based RNA-seq market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global NGS-Based RNA-Seq Market 2018 - 2022
  • Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Technology segment analysis 2018 - 2022
  • Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
6.3 Acamedic and research centers - Market size and forecast 2023-2028
  • Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
6.4 Clinical research - Market size and forecast 2023-2028
  • Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Chart on Clinical research - Year-over-year growth 2023-2028 (%)
  • Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
6.5 Pharma companies - Market size and forecast 2023-2028
  • Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
6.6 Hospitals - Market size and forecast 2023-2028
  • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technology
7.1 Market segments
  • Chart on Technology - Market share 2023-2028 (%)
  • Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
7.3 Sequencing by synthesis - Market size and forecast 2023-2028
  • Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
7.4 Ion semiconductor sequencing - Market size and forecast 2023-2028
  • Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
7.5 Single-molecule real-time sequencing - Market size and forecast 2023-2028
  • Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Singapore - Market size and forecast 2023-2028
  • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
  • Overview on factors of disruption
11.4 Industry risks
  • Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
  • Companies covered
12.2 Market positioning of companies
  • Matrix on companies position and classification
12.3 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
12.4 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key news
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
12.5 BGI Genomics Co. Ltd.
  • BGI Genomics Co. Ltd. - Overview
  • BGI Genomics Co. Ltd. - Product / Service
  • BGI Genomics Co. Ltd. - Key offerings
12.6 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key news
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
12.8 Hamilton Co.
  • Hamilton Co. - Overview
  • Hamilton Co. - Product / Service
  • Hamilton Co. - Key offerings
12.9 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
12.10 Pacific Biosciences of California Inc.
  • Pacific Biosciences of California Inc. - Overview
  • Pacific Biosciences of California Inc. - Product / Service
  • Pacific Biosciences of California Inc. - Key offerings
12.11 Perkin Elmer Inc.
  • Perkin Elmer Inc. - Overview
  • Perkin Elmer Inc. - Business segments
  • Perkin Elmer Inc. - Key news
  • Perkin Elmer Inc. - Key offerings
  • Perkin Elmer Inc. - Segment focus
12.12 Psomagen Inc.
  • Psomagen Inc. - Overview
  • Psomagen Inc. - Product / Service
  • Psomagen Inc. - Key offerings
12.13 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
12.14 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
12.15 Tecan Trading AG
  • Tecan Trading AG - Overview
  • Tecan Trading AG - Business segments
  • Tecan Trading AG - Key news
  • Tecan Trading AG - Key offerings
  • Tecan Trading AG - Segment focus
12.16 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
12.17 Zymo Research Corp.
  • Zymo Research Corp. - Overview
  • Zymo Research Corp. - Product / Service
  • Zymo Research Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
13.4 Research methodology
  • Research methodology
13.5 Data procurement
  • Information sources
13.6 Data validation
  • Data validation
13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
13.8 Data synthesis
  • Data synthesis
13.9 360 degree market analysis
  • 360 degree market analysis
13.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on End-user - Market share 2023-2028 (%)
Exhibits 33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by End-user
Exhibits 35: Data Table on Comparison by End-user
Exhibits 36: Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by End-user ($ million)
Exhibits 53: Data Table on Market opportunity by End-user ($ million)
Exhibits 54: Chart on Technology - Market share 2023-2028 (%)
Exhibits 55: Data Table on Technology - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Technology
Exhibits 57: Data Table on Comparison by Technology
Exhibits 58: Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
Exhibits 70: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 74: Market opportunity by Technology ($ million)
Exhibits 75: Data Table on Market opportunity by Technology ($ million)
Exhibits 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 79: Chart on Geographic comparison
Exhibits 80: Data Table on Geographic comparison
Exhibits 81: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 117: Market opportunity By Geographical Landscape ($ million)
Exhibits 118: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 119: Impact of drivers and challenges in 2023 and 2028
Exhibits 120: Overview on criticality of inputs and factors of differentiation
Exhibits 121: Overview on factors of disruption
Exhibits 122: Impact of key risks on business
Exhibits 123: Companies covered
Exhibits 124: Matrix on companies position and classification
Exhibits 125: Agilent Technologies Inc. - Overview
Exhibits 126: Agilent Technologies Inc. - Business segments
Exhibits 127: Agilent Technologies Inc. - Key news
Exhibits 128: Agilent Technologies Inc. - Key offerings
Exhibits 129: Agilent Technologies Inc. - Segment focus
Exhibits 130: Azenta Inc. - Overview
Exhibits 131: Azenta Inc. - Business segments
Exhibits 132: Azenta Inc. - Key news
Exhibits 133: Azenta Inc. - Key offerings
Exhibits 134: Azenta Inc. - Segment focus
Exhibits 135: BGI Genomics Co. Ltd. - Overview
Exhibits 136: BGI Genomics Co. Ltd. - Product / Service
Exhibits 137: BGI Genomics Co. Ltd. - Key offerings
Exhibits 138: Eurofins Scientific SE - Overview
Exhibits 139: Eurofins Scientific SE - Business segments
Exhibits 140: Eurofins Scientific SE - Key news
Exhibits 141: Eurofins Scientific SE - Key offerings
Exhibits 142: Eurofins Scientific SE - Segment focus
Exhibits 143: F. Hoffmann La Roche Ltd. - Overview
Exhibits 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 145: F. Hoffmann La Roche Ltd. - Key news
Exhibits 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 148: Hamilton Co. - Overview
Exhibits 149: Hamilton Co. - Product / Service
Exhibits 150: Hamilton Co. - Key offerings
Exhibits 151: Illumina Inc. - Overview
Exhibits 152: Illumina Inc. - Business segments
Exhibits 153: Illumina Inc. - Key news
Exhibits 154: Illumina Inc. - Key offerings
Exhibits 155: Illumina Inc. - Segment focus
Exhibits 156: Pacific Biosciences of California Inc. - Overview
Exhibits 157: Pacific Biosciences of California Inc. - Product / Service
Exhibits 158: Pacific Biosciences of California Inc. - Key offerings
Exhibits 159: Perkin Elmer Inc. - Overview
Exhibits 160: Perkin Elmer Inc. - Business segments
Exhibits 161: Perkin Elmer Inc. - Key news
Exhibits 162: Perkin Elmer Inc. - Key offerings
Exhibits 163: Perkin Elmer Inc. - Segment focus
Exhibits 164: Psomagen Inc. - Overview
Exhibits 165: Psomagen Inc. - Product / Service
Exhibits 166: Psomagen Inc. - Key offerings
Exhibits 167: QIAGEN NV - Overview
Exhibits 168: QIAGEN NV - Product / Service
Exhibits 169: QIAGEN NV - Key news
Exhibits 170: QIAGEN NV - Key offerings
Exhibits 171: Takara Bio Inc. - Overview
Exhibits 172: Takara Bio Inc. - Product / Service
Exhibits 173: Takara Bio Inc. - Key offerings
Exhibits 174: Tecan Trading AG - Overview
Exhibits 175: Tecan Trading AG - Business segments
Exhibits 176: Tecan Trading AG - Key news
Exhibits 177: Tecan Trading AG - Key offerings
Exhibits 178: Tecan Trading AG - Segment focus
Exhibits 179: Thermo Fisher Scientific Inc. - Overview
Exhibits 180: Thermo Fisher Scientific Inc. - Business segments
Exhibits 181: Thermo Fisher Scientific Inc. - Key news
Exhibits 182: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 183: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 184: Zymo Research Corp. - Overview
Exhibits 185: Zymo Research Corp. - Product / Service
Exhibits 186: Zymo Research Corp. - Key offerings
Exhibits 187: Inclusions checklist
Exhibits 188: Exclusions checklist
Exhibits 189: Currency conversion rates for US$
Exhibits 190: Research methodology
Exhibits 191: Information sources
Exhibits 192: Data validation
Exhibits 193: Validation techniques employed for market sizing
Exhibits 194: Data synthesis
Exhibits 195: 360 degree market analysis
Exhibits 196: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the NGS-Based RNA-Seq market: Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in next-generation sequencing techniques."

According to the report, one of the major drivers for this market is the increased adoption of next generation sequencing methods.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies Inc.
  • Azenta Inc.
  • BGI Genomics Co. Ltd.
  • DNASTAR Inc.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Hamilton Co.
  • Illumina Inc.
  • Pacific Biosciences of California Inc.
  • Perkin Elmer Inc.
  • PierianDx Inc.
  • Precigen Inc.
  • Psomagen Inc.
  • QIAGEN NV
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.